Results 261 to 270 of about 531,523 (312)
Some of the next articles are maybe not open access.

Donor-to-Donor and Donor-to-Patient Transmission of Hepatitis C Virus

Vox Sanguinis, 1996
ABSTRACTA patient was reported with suspected acute post‐transfusion hepatitis C virus (HCV) infection, 5 months after the transfusion of 2 units of red cells. The archived serum samples of the two implicated donations were retested by the original 3rd‐generation assay together with another 3rd‐generation assay and RI‐BA III, and were tested for HCV ...
A D, Kitchen, P A, Wallis, A M, Gorman
openaire   +2 more sources

When Is an Organ Donor Not an Organ Donor?

Southern Medical Journal, 2004
The Uniform Anatomical Gift Act (UAGA) grants any competent adult the legal right to designate whether he or she wishes to donate his or her organs for transplantation after death. However, contextual issues may interfere with organ donation by individuals who want to be organ donors.
Roy R, Reeves   +5 more
openaire   +2 more sources

Donor evaluation, donor risks, donor outcome, and donor quality of life in adult-to-adult living donor liver transplantation

Liver Transplantation, 2002
Right lobe living donor liver transplantation (LD-LTx) is currently performed at an increasing number of transplant centers. Donor selection, donor safety, donor recovery, and postdonation psychological impairment are essential criteria to determine whether and under which conditions LD-LTx is justifiable.
A. Pascher   +10 more
openaire   +2 more sources

Donors, donors, and more donors

Blood, 2009
In this issue of Blood, Holig and colleagues report on their 12-year experience with healthy unrelated donors. Their data outline the challenges involved in safeguarding donor safety and the need for ongoing surveillance.
openaire   +2 more sources

Treating the donor

Current Opinion in Organ Transplantation, 2014
Current pressures of organ supply and demand require maximization of potential for organ donation. The donor population is older and has more significant comorbidity than in the past.Optimal management of the donor after brain death (DBD) is essential to ensure that the greatest number of organs can be transplanted per donor.
Dermot W, McKeown, Jonathan, Ball
openaire   +2 more sources

The Pulmonary Donor

Clinics in Chest Medicine, 1990
This article discusses the Pittsburgh experience with the pulmonary donor and provides guidelines for the maintenance and selection of appropriate donor lungs. Criteria for the selection of the pulmonary donor include absence of radiographic abnormality, minimal ventilation-perfusion mismatch, and an absence of identifiable infection.
B P, Griffith, M, Zenati
openaire   +2 more sources

The Organ Donor

Critical Care Clinics, 1990
Vascularized organ transplantation is now a widely applied therapy for patients with end-stage diseases of the heart, lungs, liver, kidneys, and pancreas. A critical shortage of donor organs exists in the United States and, as a consequence, prospective transplant recipients die while waiting for a life-saving transplant.
K L, Brayman   +4 more
openaire   +2 more sources

NADH as Donor

EcoSal Plus, 2007
The number of NADH dehydrogenases and their role in energy transduction in Escherchia coli have been under debate for a long time. Now it is evident that E. coli possesses two respiratory NADH dehydrogenases, or NADH:ubiquinone oxidoreductases, that have traditionally been called NDH-I and ...
Friedrich, Thorsten, Pohl, Thomas
openaire   +3 more sources

Cadaveric donors

Anesthesiology Clinics of North America, 2004
The diagnosis of brain death describes the final catastrophic state of a person for whom, except for ventilators and pharmacology, death would surely have already intervened. Although we think of death as an ending, if the patient becomes an organ donor it is also a beginning.
openaire   +2 more sources

The Use of Neoplastic Donors to Increase the Donor Pool

Transplantation Proceedings, 2012
The aim of the study was to evaluate the experience of the Centre-Sud Transplant Organization (OCST) area using cadaveric donor with neoplastic diseases to evaluate the possibility of transmission to recipients. From January 1, 2003, to December 31, 2010, the neoplastic risk has been reported to be 5.4% (377/4654 referred donors).
P. Fiaschetti   +9 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy